An exploration of factors influencing attrition from a pediatric weight management intervention

Melissa Kwitowski1, Melanie K Bean2, Suzanne E Mazzeo3

  • 1Department of Psychology, Virginia Commonwealth University, P.O. Box 842018, Richmond, VA 23284-2018, USA.

Insights

High attrition in pediatric weight management affects low-income and minority families. Addressing practical barriers and improving child engagement in treatments like NOURISH+ may reduce dropout and enhance outcomes for childhood obesity.

Area of Science:

  • Public Health
  • Pediatric Medicine
  • Behavioral Science

Background:

  • Pediatric obesity presents a significant public health challenge.
  • High treatment attrition rates disproportionately affect lower-income and ethnic minority populations, hindering effective childhood weight management.
  • The NOURISH+ program is a parent-exclusive intervention for overweight or obese children aged 5-11.

Purpose of the Study:

  • To investigate attrition barriers within at-risk families participating in the NOURISH+ childhood weight management program.
  • To identify specific challenges faced by low-income and racially diverse families in adhering to treatment.

Main Methods:

  • A survey was administered to NOURISH+ participants to assess barriers to treatment adherence.
  • Qualitative and quantitative data analysis to understand caregiver-reported challenges.

Main Results:

  • Practical barriers represent significant concerns for low-income, racially diverse families undergoing the NOURISH+ program.
  • The parent-exclusive nature of NOURISH+, despite empirical support, may not align with caregiver expectations.
  • Caregiver expectations and practical challenges were identified as key factors influencing adherence.

Conclusions:

  • Addressing practical barriers and aligning treatment with caregiver expectations are crucial for reducing attrition in pediatric obesity interventions.
  • Enhancing child engagement within weight management programs may improve treatment adherence and outcomes.
  • Future interventions should consider practical support and caregiver-child dyadic engagement to improve pediatric obesity treatment effectiveness.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
329